Drug-matching trial for adults with cancer DNA changes
Part of Blood & lymphatic, Cancer clinical trials.
This trial looks for the specific DNA or tumor changes in your cancer and then matches you to a targeted drug plan. It’s meant for people with early cancer that has not already been treated in this study.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You must have a solid tumor cancer or a blood cancer (hematologic malignancy)
- You must have the specific requested tumor DNA change (listed as “MSA9”) being deleted
- You must be able to provide signed consent before any trial procedures
- You must live within France’s rules for biomedical research paperwork (social security requirements)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the genetic makeup of your tumor to find personalized treatment options, especially if standard treatments have not worked. It aims to match you with experimental treatments that target your cancer's specific changes.
This study helps doctors use more individualized (precision) treatment choices for people with certain advanced cancers. You may be offered study care based on your cancer details, aiming to improve treatment decisions.
This study helps doctors better understand your cancer by doing tumor/cancer profiling as part of research. If you qualify, your participation may help improve how cancers are studied and matched with future treatments.
This trial takes a sample of your tumor during a standard procedure to grow it in a lab and test different drugs. The goal is to find which drugs might work best for people with your specific tumor DNA change.
This study uses a simple blood test to look at the genetic makeup of your tumor. The results may help your doctors choose the best treatment for you. You will need to provide a tumor sample or have a biopsy.
This trial tests whether tailoring treatment to your tumor's specific genetic makeup can help when standard treatments are no longer working. It may give you access to therapies that are more likely to work for your cancer.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.